GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Protein Tat
I7FRF9_9HIV1 Unreviewed; 102 AA.
I7FRF9;
03-OCT-2012, integrated into UniProtKB/TrEMBL.
03-OCT-2012, sequence version 1.
28-MAR-2018, entry version 20.
RecName: Full=Protein Tat {ECO:0000256|HAMAP-Rule:MF_04079, ECO:0000256|RuleBase:RU003311, ECO:0000256|SAAS:SAAS00396010};
AltName: Full=Transactivating regulatory protein {ECO:0000256|HAMAP-Rule:MF_04079};
Name=tat {ECO:0000256|HAMAP-Rule:MF_04079,
ECO:0000313|EMBL:AFP25845.1};
Human immunodeficiency virus 1.
Viruses; Retro-transcribing viruses; Retroviridae; Orthoretrovirinae;
Lentivirus; Primate lentivirus group.
NCBI_TaxID=11676 {ECO:0000313|EMBL:AFP25845.1};
NCBI_TaxID=9606; Homo sapiens (Human).
[1] {ECO:0000313|EMBL:AFP25845.1}
NUCLEOTIDE SEQUENCE.
STRAIN=703010256.e10 {ECO:0000313|EMBL:AFP25740.1},
703010256.e11 {ECO:0000313|EMBL:AFP25748.1},
703010256.e12 {ECO:0000313|EMBL:AFP25756.1},
703010256.e13 {ECO:0000313|EMBL:AFP25762.1},
703010256.e22 {ECO:0000313|EMBL:AFP25825.1},
703010256.e23 {ECO:0000313|EMBL:AFP25831.1},
703010256.e25 {ECO:0000313|EMBL:AFP25845.1},
703010256.e27 {ECO:0000313|EMBL:AFP25859.1}, and
703010256.e8 {ECO:0000313|EMBL:AFP25887.1};
PubMed=22693444; DOI=10.1371/journal.ppat.1002686;
Parrish N.F., Wilen C.B., Banks L.B., Iyer S.S., Pfaff J.M.,
Salazar-Gonzalez J.F., Salazar M.G., Decker J.M., Parrish E.H.,
Berg A., Hopper J., Hora B., Kumar A., Mahlokozera T., Yuan S.,
Coleman C., Vermeulen M., Ding H., Ochsenbauer C., Tilton J.C.,
Permar S.R., Kappes J.C., Betts M.R., Busch M.P., Gao F.,
Montefiori D., Haynes B.F., Shaw G.M., Hahn B.H., Doms R.W.;
"Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5
receptors with equal efficiency and are not inhibited by blocking the
integrin alpha4beta7.";
PLoS Pathog. 8:E1002686-E1002686(2012).
[2] {ECO:0000313|EMBL:AGG96148.1}
NUCLEOTIDE SEQUENCE.
STRAIN=C.703010256.w24.172dps.e1 {ECO:0000313|EMBL:AGG96148.1},
C.703010256.w24.172dps.e12 {ECO:0000313|EMBL:AGG96154.1},
C.703010256.w24.172dps.e5 {ECO:0000313|EMBL:AGG96182.1},
C.703010256.w60.426dps.e1 {ECO:0000313|EMBL:AGG96216.1},
C.703010256.w60.426dps.e12 {ECO:0000313|EMBL:AGG96236.1},
C.703010256.w60.426dps.e13 {ECO:0000313|EMBL:AGG96243.1},
C.703010256.w60.426dps.e18 {ECO:0000313|EMBL:AGG96263.1},
C.703010256.w60.426dps.e2 {ECO:0000313|EMBL:AGG96270.1},
C.703010256.w60.426dps.e3 {ECO:0000313|EMBL:AGG96276.1},
C.703010256.w60.426dps.e4 {ECO:0000313|EMBL:AGG96283.1},
C.703010256.w60.426dps.e8 {ECO:0000313|EMBL:AGG96303.1},
C.703010256.w60.426dps.e9 {ECO:0000313|EMBL:AGG96310.1},
C.703010256.w96.684dps.e10 {ECO:0000313|EMBL:AGG96324.1},
C.703010256.w96.684dps.e11 {ECO:0000313|EMBL:AGG96331.1},
C.703010256.w96.684dps.e12 {ECO:0000313|EMBL:AGG96338.1},
C.703010256.w96.684dps.e13 {ECO:0000313|EMBL:AGG96344.1},
C.703010256.w96.684dps.e22 {ECO:0000313|EMBL:AGG96407.1},
C.703010256.w96.684dps.e23 {ECO:0000313|EMBL:AGG96413.1},
C.703010256.w96.684dps.e25 {ECO:0000313|EMBL:AGG96427.1},
C.703010256.w96.684dps.e27 {ECO:0000313|EMBL:AGG96441.1}, and
C.703010256.w96.684dps.e8 {ECO:0000313|EMBL:AGG96469.1};
PubMed=23221345; DOI=10.1172/JCI65330;
CHAVI Core B;
Liu M.K., Hawkins N., Ritchie A.J., Ganusov V.V., Whale V.,
Brackenridge S., Li H., Pavlicek J.W., Cai F., Rose-Abrahams M.,
Treurnicht F., Hraber P., Riou C., Gray C., Ferrari G., Tanner R.,
Ping L.H., Anderson J.A., Swanstrom R., B C.C., Cohen M., Karim S.S.,
Haynes B., Borrow P., Perelson A.S., Shaw G.M., Hahn B.H.,
Williamson C., Korber B.T., Gao F., Self S., McMichael A.,
Goonetilleke N.;
"Vertical T cell immunodominance and epitope entropy determine HIV-1
escape.";
J. Clin. Invest. 123:380-393(2013).
-!- FUNCTION: Extracellular circulating Tat can be endocytosed by
surrounding uninfected cells via the binding to several surface
receptors such as CD26, CXCR4, heparan sulfate proteoglycans
(HSPG) or LDLR. Neurons are rarely infected, but they internalize
Tat via their LDLR. Through its interaction with nuclear HATs, Tat
is potentially able to control the acetylation-dependent cellular
gene expression. Modulates the expression of many cellular genes
involved in cell survival, proliferation or in coding for
cytokines or cytokine receptors. Tat plays a role in T-cell and
neurons apoptosis. Tat induced neurotoxicity and apoptosis
probably contribute to neuroAIDS. Circulating Tat also acts as a
chemokine-like and/or growth factor-like molecule that binds to
specific receptors on the surface of the cells, affecting many
cellular pathways. In the vascular system, Tat binds to
ITGAV/ITGB3 and ITGA5/ITGB1 integrins dimers at the surface of
endothelial cells and competes with bFGF for heparin-binding
sites, leading to an excess of soluble bFGF. {ECO:0000256|HAMAP-
Rule:MF_04079}.
-!- FUNCTION: Nuclear transcriptional activator of viral gene
expression, that is essential for viral transcription from the LTR
promoter and replication. Acts as a sequence-specific molecular
adapter, directing components of the cellular transcription
machinery to the viral RNA to promote processive transcription
elongation by the RNA polymerase II (RNA pol II) complex, thereby
increasing the level of full-length transcripts. In the absence of
Tat, the RNA Pol II generates short or non-processive transcripts
that terminate at approximately 60 bp from the initiation site.
Tat associates with the CCNT1/cyclin-T1 component of the P-TEFb
complex (CDK9 and CCNT1), which promotes RNA chain elongation.
This binding increases Tat's affinity for a hairpin structure at
the 5'-end of all nascent viral mRNAs referred to as the
transactivation responsive RNA element (TAR RNA) and allows Tat/P-
TEFb complex to bind cooperatively to TAR RNA. The CDK9 component
of P-TEFb and other Tat-activated kinases hyperphosphorylate the
C-terminus of RNA Pol II that becomes stabilized and much more
processive. Other factors such as HTATSF1/Tat-SF1, SUPT5H/SPT5,
and HTATIP2 are also important for Tat's function. Besides its
effect on RNA Pol II processivity, Tat induces chromatin
remodeling of proviral genes by recruiting the histone
acetyltransferases (HATs) CREBBP, EP300 and PCAF to the chromatin.
This also contributes to the increase in proviral transcription
rate, especially when the provirus integrates in transcriptionally
silent region of the host genome. To ensure maximal activation of
the LTR, Tat mediates nuclear translocation of NF-kappa-B by
interacting with host RELA. Through its interaction with host TBP,
Tat may also modulate transcription initiation. Tat can reactivate
a latently infected cell by penetrating in it and transactivating
its LTR promoter. In the cytoplasm, Tat is thought to act as a
translational activator of HIV-1 mRNAs. {ECO:0000256|HAMAP-
Rule:MF_04079}.
-!- SUBUNIT: Interacts with host CCNT1. Associates with the P-TEFb
complex composed at least of Tat, P-TEFb (CDK9 and CCNT1), TAR
RNA, RNA Pol II. Recruits the HATs CREBBP, TAF1/TFIID, EP300, PCAF
and GCN5L2. Interacts with host KAT5/Tip60; this interaction
targets the latter to degradation. Interacts with the host
deacetylase SIRT1. Interacts with host capping enzyme RNGTT; this
interaction stimulates RNGTT. Binds to host KDR, and to the host
integrins ITGAV/ITGB3 and ITGA5/ITGB1. Interacts with host
KPNB1/importin beta-1 without previous binding to KPNA1/importin
alpha-1. Interacts with EIF2AK2. Interacts with host nucleosome
assembly protein NAP1L1; this interaction may be required for the
transport of Tat within the nucleus, since the two proteins
interact at the nuclear rim. Interacts with host C1QBP/SF2P32;
this interaction involves lysine-acetylated Tat. Interacts with
the host chemokine receptors CCR2, CCR3 and CXCR4. Interacts with
host DPP4/CD26; this interaction may trigger an anti-proliferative
effect. Interacts with host LDLR. Interacts with the host
extracellular matrix metalloproteinase MMP1. Interacts with host
PRMT6; this interaction mediates Tat's methylation. Interacts
with, and is ubiquitinated by MDM2/Hdm2. Interacts with host PSMC3
and HTATIP2. Interacts with STAB1; this interaction may overcome
SATB1-mediated repression of IL2 and IL2RA (interleukin) in T
cells by binding to the same domain than HDAC1. Interacts (when
acetylated) with human CDK13, thereby increasing HIV-1 mRNA
splicing and promoting the production of the doubly spliced HIV-1
protein Nef.Interacts with host TBP; this interaction modulates
the activity of transcriptional pre-initiation complex. Interacts
with host RELA. {ECO:0000256|HAMAP-Rule:MF_04079}.
-!- SUBCELLULAR LOCATION: Host nucleus, host nucleolus
{ECO:0000256|HAMAP-Rule:MF_04079}. Host cytoplasm
{ECO:0000256|HAMAP-Rule:MF_04079}. Secreted {ECO:0000256|HAMAP-
Rule:MF_04079}. Note=Probably localizes to both nuclear and
nucleolar compartments. Nuclear localization is mediated through
the interaction of the nuclear localization signal with importin
KPNB1. Secretion occurs through a Golgi-independent pathway. Tat
is released from infected cells to the extracellular space where
it remains associated to the cell membrane, or is secreted into
the cerebrospinal fluid and sera. Extracellular Tat can be
endocytosed by surrounding uninfected cells via binding to several
receptors depending on the cell type. {ECO:0000256|HAMAP-
Rule:MF_04079}.
-!- DOMAIN: The Arg-rich RNA-binding region binds the TAR RNA. This
region also mediates the nuclear localization through direct
binding to KPNB1 and is involved in Tat's transfer across cell
membranes (protein transduction). The same region is required for
the interaction with EP300, PCAF, EIF2AK2 and KDR.
{ECO:0000256|HAMAP-Rule:MF_04079}.
-!- DOMAIN: The Cys-rich region may bind 2 zinc ions. This region is
involved in binding to KAT5. {ECO:0000256|HAMAP-Rule:MF_04079}.
-!- DOMAIN: The cell attachment site mediates the interaction with
ITGAV/ITGB3 and ITGA5/ITGB1 integrins, leading to vascular cell
migration and invasion. This interaction also provides endothelial
cells with the adhesion signal they require to grow in response to
mitogens. {ECO:0000256|HAMAP-Rule:MF_04079}.
-!- DOMAIN: The transactivation domain mediates the interaction with
CCNT1, GCN5L2, and MDM2. {ECO:0000256|HAMAP-Rule:MF_04079}.
-!- PTM: Acetylation by EP300, CREBBP, GCN5L2/GCN5 and PCAF regulates
the transactivation activity of Tat. EP300-mediated acetylation of
Lys-50 promotes dissociation of Tat from the TAR RNA through the
competitive binding to PCAF's bromodomain. In addition, the non-
acetylated Tat's N-terminus can also interact with PCAF. PCAF-
mediated acetylation of Lys-28 enhances Tat's binding to CCNT1.
Lys-50 is deacetylated by SIRT1. {ECO:0000256|HAMAP-
Rule:MF_04079}.
-!- PTM: Asymmetrical arginine methylation by host PRMT6 seems to
diminish the transactivation capacity of Tat and affects the
interaction with host CCNT1. {ECO:0000256|HAMAP-Rule:MF_04079}.
-!- PTM: Phosphorylated by EIF2AK2 on serine and threonine residues
adjacent to the basic region important for TAR RNA binding and
function. Phosphorylation of Tat by EIF2AK2 is dependent on the
prior activation of EIF2AK2 by dsRNA. {ECO:0000256|HAMAP-
Rule:MF_04079}.
-!- PTM: Polyubiquitination by host MDM2 does not target Tat to
degradation, but activates its transactivation function and
fosters interaction with CCNT1 and TAR RNA. {ECO:0000256|HAMAP-
Rule:MF_04079}.
-!- MISCELLANEOUS: HIV-1 lineages are divided in three main groups, M
(for Major), O (for Outlier), and N (for New, or Non-M, Non-O).
The vast majority of strains found worldwide belong to the group
M. Group O seems to be endemic to and largely confined to Cameroon
and neighboring countries in West Central Africa, where these
viruses represent a small minority of HIV-1 strains. The group N
is represented by a limited number of isolates from Cameroonian
persons. The group M is further subdivided in 9 clades or subtypes
(A to D, F to H, J and K). {ECO:0000256|HAMAP-Rule:MF_04079}.
-!- SIMILARITY: Belongs to the lentiviruses Tat family.
{ECO:0000256|HAMAP-Rule:MF_04079, ECO:0000256|RuleBase:RU003311,
ECO:0000256|SAAS:SAAS00581731}.
-!- CAUTION: Lacks conserved residue(s) required for the propagation
of feature annotation. {ECO:0000256|HAMAP-Rule:MF_04079}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; JQ779075; AFP25740.1; -; Genomic_RNA.
EMBL; JQ779076; AFP25748.1; -; Genomic_RNA.
EMBL; JQ779077; AFP25756.1; -; Genomic_RNA.
EMBL; JQ779078; AFP25762.1; -; Genomic_RNA.
EMBL; JQ779087; AFP25825.1; -; Genomic_RNA.
EMBL; JQ779088; AFP25831.1; -; Genomic_RNA.
EMBL; JQ779090; AFP25845.1; -; Genomic_RNA.
EMBL; JQ779092; AFP25859.1; -; Genomic_RNA.
EMBL; JQ779096; AFP25887.1; -; Genomic_RNA.
EMBL; JX972789; AGG96148.1; -; Genomic_RNA.
EMBL; JX972790; AGG96154.1; -; Genomic_RNA.
EMBL; JX972794; AGG96182.1; -; Genomic_RNA.
EMBL; JX972799; AGG96216.1; -; Genomic_RNA.
EMBL; JX972802; AGG96236.1; -; Genomic_RNA.
EMBL; JX972803; AGG96243.1; -; Genomic_RNA.
EMBL; JX972806; AGG96263.1; -; Genomic_RNA.
EMBL; JX972807; AGG96270.1; -; Genomic_RNA.
EMBL; JX972808; AGG96276.1; -; Genomic_RNA.
EMBL; JX972809; AGG96283.1; -; Genomic_RNA.
EMBL; JX972812; AGG96303.1; -; Genomic_RNA.
EMBL; JX972813; AGG96310.1; -; Genomic_RNA.
EMBL; JX972815; AGG96324.1; -; Genomic_RNA.
EMBL; JX972816; AGG96331.1; -; Genomic_RNA.
EMBL; JX972817; AGG96338.1; -; Genomic_RNA.
EMBL; JX972818; AGG96344.1; -; Genomic_RNA.
EMBL; JX972827; AGG96407.1; -; Genomic_RNA.
EMBL; JX972828; AGG96413.1; -; Genomic_RNA.
EMBL; JX972830; AGG96427.1; -; Genomic_RNA.
EMBL; JX972832; AGG96441.1; -; Genomic_RNA.
EMBL; JX972836; AGG96469.1; -; Genomic_RNA.
GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
GO; GO:0044196; C:host cell nucleolus; IEA:UniProtKB-SubCell.
GO; GO:0042805; F:actinin binding; IEA:UniProtKB-UniRule.
GO; GO:0030332; F:cyclin binding; IEA:UniProtKB-UniRule.
GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule.
GO; GO:0019904; F:protein domain specific binding; IEA:UniProtKB-UniRule.
GO; GO:0001070; F:RNA binding transcription regulator activity; IEA:UniProtKB-UniRule.
GO; GO:1990970; F:trans-activation response element binding; IEA:UniProtKB-UniRule.
GO; GO:0039525; P:modulation by virus of host chromatin organization; IEA:UniProtKB-UniRule.
GO; GO:0039586; P:modulation by virus of host PP1 activity; IEA:UniProtKB-UniRule.
GO; GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; IEA:UniProtKB-UniRule.
GO; GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IEA:UniProtKB-UniRule.
GO; GO:0050434; P:positive regulation of viral transcription; IEA:UniProtKB-UniRule.
GO; GO:0039502; P:suppression by virus of host type I interferon-mediated signaling pathway; IEA:UniProtKB-UniRule.
GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
Gene3D; 4.10.20.10; -; 1.
HAMAP; MF_04079; HIV_TAT; 1.
InterPro; IPR001831; IV_Tat.
InterPro; IPR036963; Tat_dom_sf.
Pfam; PF00539; Tat; 1.
PRINTS; PR00055; HIVTATDOMAIN.
3: Inferred from homology;
Acetylation {ECO:0000256|HAMAP-Rule:MF_04079};
Activator {ECO:0000256|HAMAP-Rule:MF_04079,
ECO:0000256|RuleBase:RU003311, ECO:0000256|SAAS:SAAS00111091};
Apoptosis {ECO:0000256|HAMAP-Rule:MF_04079};
Host cytoplasm {ECO:0000256|HAMAP-Rule:MF_04079};
Host nucleus {ECO:0000256|HAMAP-Rule:MF_04079,
ECO:0000256|RuleBase:RU003311, ECO:0000256|SAAS:SAAS00473431};
Host-virus interaction {ECO:0000256|HAMAP-Rule:MF_04079};
Inhibition of host innate immune response by virus {ECO:0000256|HAMAP-
Rule:MF_04079};
Inhibition of host interferon signaling pathway by virus
{ECO:0000256|HAMAP-Rule:MF_04079};
Isopeptide bond {ECO:0000256|HAMAP-Rule:MF_04079};
Metal-binding {ECO:0000256|HAMAP-Rule:MF_04079};
Methylation {ECO:0000256|HAMAP-Rule:MF_04079};
Modulation of host chromatin by virus {ECO:0000256|HAMAP-
Rule:MF_04079};
Modulation of host PP1 activity by virus {ECO:0000256|HAMAP-
Rule:MF_04079}; Phosphoprotein {ECO:0000256|HAMAP-Rule:MF_04079};
RNA-binding {ECO:0000256|HAMAP-Rule:MF_04079,
ECO:0000256|RuleBase:RU003311, ECO:0000256|SAAS:SAAS00111359};
Secreted {ECO:0000256|HAMAP-Rule:MF_04079};
Transcription {ECO:0000256|HAMAP-Rule:MF_04079,
ECO:0000256|RuleBase:RU003311, ECO:0000256|SAAS:SAAS00111074};
Transcription regulation {ECO:0000256|HAMAP-Rule:MF_04079,
ECO:0000256|RuleBase:RU003311, ECO:0000256|SAAS:SAAS00111074};
Ubl conjugation {ECO:0000256|HAMAP-Rule:MF_04079};
Viral immunoevasion {ECO:0000256|HAMAP-Rule:MF_04079};
Zinc {ECO:0000256|HAMAP-Rule:MF_04079}.
REGION 1 48 Transactivation. {ECO:0000256|HAMAP-
Rule:MF_04079}.
REGION 1 24 Interaction with human CREBBP.
{ECO:0000256|HAMAP-Rule:MF_04079}.
REGION 22 37 Cysteine-rich. {ECO:0000256|HAMAP-
Rule:MF_04079}.
REGION 38 48 Core. {ECO:0000256|HAMAP-Rule:MF_04079}.
REGION 49 86 Interaction with the host capping enzyme
RNGTT. {ECO:0000256|HAMAP-Rule:MF_04079}.
MOTIF 49 57 Nuclear localization signal, RNA-binding
(TAR), and protein transduction.
{ECO:0000256|HAMAP-Rule:MF_04079}.
METAL 22 22 Zinc 1. {ECO:0000256|HAMAP-
Rule:MF_04079}.
METAL 25 25 Zinc 2. {ECO:0000256|HAMAP-
Rule:MF_04079}.
METAL 27 27 Zinc 2. {ECO:0000256|HAMAP-
Rule:MF_04079}.
METAL 30 30 Zinc 2. {ECO:0000256|HAMAP-
Rule:MF_04079}.
METAL 33 33 Zinc 1; via pros nitrogen.
{ECO:0000256|HAMAP-Rule:MF_04079}.
METAL 34 34 Zinc 1. {ECO:0000256|HAMAP-
Rule:MF_04079}.
METAL 37 37 Zinc 1. {ECO:0000256|HAMAP-
Rule:MF_04079}.
SITE 11 11 Essential for Tat translocation through
the endosomal membrane.
{ECO:0000256|HAMAP-Rule:MF_04079}.
MOD_RES 28 28 N6-acetyllysine; by host PCAF.
{ECO:0000256|HAMAP-Rule:MF_04079}.
MOD_RES 50 50 N6-acetyllysine; by host EP300 and
GCN5L2. {ECO:0000256|HAMAP-
Rule:MF_04079}.
MOD_RES 51 51 N6-acetyllysine; by host EP300 and
GCN5L2. {ECO:0000256|HAMAP-
Rule:MF_04079}.
MOD_RES 52 52 Asymmetric dimethylarginine; by host
PRMT6. {ECO:0000256|HAMAP-Rule:MF_04079}.
MOD_RES 53 53 Asymmetric dimethylarginine; by host
PRMT6. {ECO:0000256|HAMAP-Rule:MF_04079}.
CROSSLNK 71 71 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in ubiquitin).
{ECO:0000256|HAMAP-Rule:MF_04079}.
SEQUENCE 102 AA; 11646 MW; 2BB4001B777F2251 CRC64;
MEPIDPKLEP WNHPGSQPKT ACNKCYCKKC SYHCLVCFQT KGLGISYGRK KRRQRRSAPP
SSEDHQNPLP KQPLSQTRGN PTGSEESKKK VESQTETDPF DW
Related products :
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Pathways :
WP1624: Bacterial secretion system
WP1692: Protein export
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1657: Glycerolipid metabolism
WP1659: Glycine, serine and threonine metabolism
WP1661: Glyoxylate and dicarboxylate metabolism
WP1663: Homologous recombination
WP1665: Limonene and pinene degradation
WP1672: Mismatch repair
WP1673: Naphthalene and anthracene degradation
WP1675: Nitrogen metabolism
WP1676: Non-homologous end-joining
Related Genes :
[L1] Major capsid protein L1 (Fragment)
[] Genome polyprotein [Cleaved into: P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); P2; Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); P3; Protein 3AB; Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: Protein VP0 (VP4-VP2); Protein VP4 (P1A) (Virion protein 4); Protein VP2 (P1B) (Virion protein 2); Protein VP3 (P1C) (Virion protein 3); Protein VP1-2A (PX); Protein VP1 (P1D) (Virion protein 1); Protein 2A (P2A); Protein 2BC; Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3ABCD (P3); Protein 3ABC; Protein 3AB; Protein 3A (P3A); Protein 3B (P3B) (VPg); Protein 3CD; Protease 3C (P3C) (EC 3.4.22.28) (Picornain 3C); RNA-directed RNA polymerase 3D-POL (P3D-POL) (EC 2.7.7.48)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); P2; Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); P2; Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); P2; Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
Bibliography :
No related Items
Enter catalog number :
Favorites Pages:
No Favorits